Green route for the heterocyclization of 2-mercaptobenzimidazole into β-lactum segment derivatives containing -CONH- bridge with benzimidazole: Screening in vitro antimicrobial activity with various microorganisms

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 24, 2006, Pages 8271-8279

  Desai, Krunal G ^a   Desai, Kishor R ^a  

^a Synthetic Organic Chemistry Research Laboratory   (India)

Author keywords

2 Azetidinones; Antimicrobial interest; Heterocyclization; Microwave effect

Indexed keywords

1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (2 CHLOROPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (2 HYDROXYPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (2 METHOXYPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (3 CHLOROPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (3 HYDROXYPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (3,4,5 TRIMETHOXYPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (4 CHLOROPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (4 HYDROXYPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (4 METHOXYPHENYLAZETIDIN 2' ONE); 1' [(BENZIMIDAZOL 2 YL)THIOACETAMIDYL] 3' CHLORO 4' (4 NITROPHENYLAZETIDIN 2' ONE); 2 BENZIMIDAZOLETHIOL DERIVATIVE; ACETIC ACID DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BENZIMIDAZOLE; BETA LACTAM DERIVATIVE; CHLOROACETYL CHLORIDE; TERBINAFINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; CANDIDA KRUSEI; CATALYST; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; MICROWAVE RADIATION; NONHUMAN; POLYMERIZATION; STAPHYLOCOCCUS AUREUS; SUBSTITUTION REACTION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLUS NIGER; BENZIMIDAZOLES; CANDIDA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MICROWAVES;

EID: 33750525295     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.09.017     Document Type: Article

References (38)

1. Guru N., and Srivastava S.D. J. Sci. Ind. Res. 60 (2001) 601
2. Muhammad M., and Bhat I. Indian J. Heterocycl. Chem. 13 (2003) 183
3. Biradar J.S., and Manjunath. Indian J. Chem. (B) 43B (2004) 141
4. Sharma P., and Kumar A. Indian J. Chem. (B) 43B (2004) 385
5. Desai J.M., and Shah V.H. Indian J. Chem. (B) 42B (2003) 631
6. Banik B.K., Becker F.F., and Banik I. Bioorg. Med. Chem. 12 10 (2004) 2523
7. Banik I., Becker F.F., and Banik B.K. J. Med. Chem 46 1 (2003) 12
8. Anaya J., Gero D.S., Grande M., Hernando J.I.M., and Laso N.M. Bioorg. Med. Chem. 7 5 (1999) 837
9. Gerona-Navarro G., Perez de Vega M.J., Garcia-Lopez M.T., Andrei G., Snoeck R., De Clercq E., Balzarini J., and Gonzalez-Muniz R. J. Med. Chem. 48 7 (2005) 2612
10. Singh G.S., and Mmolotsi B.J. IL Farmaco 60 9 (2005) 727
11. Güner V., Yi{dotless}ldi{dotless}ri{dotless}r S., Özçeli{dotless}k B., and Abbaso Lu.U. IL Farmaco 55 2 (2000) 147
12. Veinberg G., Shestakova I., Vorona M., Kanepe I., and Lukevics E. Bioorg. Med. Chem. Lett. 14 (2004) 47
13. Gerona-Navarro G., Jesús Pérez de Vega M., Teresa García-López M., Andrei G., Snoeck R., Balzarini J., De Clercq E., and González-Muñiz R. Bioorg. Med. Chem. Lett. 14 9 (2004) 2253
14. Afonso A., Hon F., Fett N., Weinstein J., Ganguly A.K., Naples L., Hare R.S., and Miller G.H. Bioorg. Med. Chem. Lett. 8 (1998) 2793
15. Aoyama Y., Uenaka M., Kii M., Tanaka M., Konoike T., Hayasaki-Kajiwara Y., Naya N., and Nakajima M. Bioorg. Med. Chem. 9 (2001) 3065
16. Varma S. Green Chem. 1 (1999) 43
17. Desai K.G., and Desai K.R. J. Sulfur Chem. (Taylor and Francis Groups) 27 (2006) 315
18. Borah R., Kalita D.J., and Sharma J.C. Indian J. Chem 41B (2002) 1032
19. Kidwai M., and Dave B. Indian J. Chem 41B (2002) 2430
20. Patel, V. M.; Desai, K. R.; ARKIVOC (USA) (www.arkat-usa.org). 2004, 1, 123.
21. Desai K.G., Desai K.R., and Raval J.P. J. Iranian Chem. Soc. 3 (2006) 233
22. Desai, K. G.; Desai, K. R.; Molbank (www.mdpi.org/molbank) (Switzerland), 2006, M475 (MOL File: m477.mol).
23. Desai, K. G.; Desai, K. R.; D. Padmanabhan.; Molbank (www.mdpi.org/molbank) (Switzerland), 2006, M475 (MOL File: m478.mol)
24. Desai K.G., and Desai K.R. Indian J. Chem. (B) B (2005) 2096
25. Desai K.G., and Desai K.R. Indian J. Chem. (B) 44B (2005) 2093
26. Desai K.G., and Desai K.R. J. Saudi Chem. Soc. 9 (2006) 631
27. Loupy A., Perreux L., and Moneuse M. Pure. Appl. Chem. 11 (2001) 161
28. National committee for clinical laboratory standards, 1997, Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard NCCLS document M27 A. (ISBN 1 56238 328 0, ISSN 0273 3099). National committee for clinical laboratory standards, 940, West Valley Road, Suite 1400, Wayne, Pennsylvania, 19807.
29. Kidwai M., and Mothsra P. Syn. Commun. 36 (2006) 817
30. National committee for clinical laboratory standards, 2000.
31. National committee for clinical laboratory standards, 1997.
32. National committee for clinical laboratory standards, 1998.
33. Fernandez B., Cabanes A.J., and Inza I. J. Clin. Microb. 40 (2002) 4003
34. Desai K.G., and Desai K.R. J. Heterocyclic Chem. 43 (2006) 1083
35. Fernandez B., Carillo A.J., and Martin E. Antimicrob. Agents Chemother. 45 (2001) 2528
36. Gupta A.K., and Kohli Y. Brit. J. Dermatol. 149 (2003) 305
37. Kigh C.W., Famthing R.A., and Rinaldi M.G. J. Clin. Microb. 30 (1992) 3145
38. Berenguer J., Sanchez R., and Matinez J.V. Antimicrob. Agents Chemother. 40 (1996) 2003